临床和实验医学杂志
臨床和實驗醫學雜誌
림상화실험의학잡지
JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE
2015年
16期
1356-1358
,共3页
急性髓性白血病%T 淋巴细胞亚群%细胞因子
急性髓性白血病%T 淋巴細胞亞群%細胞因子
급성수성백혈병%T 림파세포아군%세포인자
Acute myeloid leukemia%T - lymphocyte subsets%Th1 / Th2 cytokines
目的:探讨急性髓性白血病(AML)患者外周血 T 淋巴细胞亚群及 Th1/ Th2细胞因子的变化及临床意义。方法采用流式细胞仪及酶联免疫吸附法(ELISA)分别检测50例健康者及30例 AML 患者治疗前后 T 淋巴细胞亚群及 Th1/ Th2细胞因子水平。结果初诊 AML 患者外周血 CD3+、CD4+、CD4+/ CD8+均显著低于健康组,CD8+显著高于健康组,差异具有统计学意义( P ﹤0.05)。治疗后,AML 组患者外周血 CD3+、CD4+、CD4+/ CD8+均显著升高,CD8+显著降低,与初诊时比较差异具有统计学意义( P ﹤0.05),但与健康组比较差异仍具有统计学意义( P ﹤0.05)。初诊AML 患者外周血白介素2(IL -2)、干扰素(IFN -γ)均显著低于健康组,IL -4、IL -10显著高于健康组,差异具有统计学意义( P ﹤0.05)。治疗后,AML 组患者外周血 IL -2、IFN -γ均显著升高,IL -4、IL -10显著降低,与初诊时比较差异具有统计学意义( P ﹤0.05),但与健康组比较差异仍具有统计学意义( P ﹤0.05)。结论 T 淋巴细胞亚群及 Th1/Th2细胞因子对 AML 患者病情评估、疗效判定及预后评估具有一定临床价值。以调节 T 淋巴细胞亚群及 Th1/ Th2细胞因子为免疫治疗方案,可能为 AML 的临床治疗提供新思路。
目的:探討急性髓性白血病(AML)患者外週血 T 淋巴細胞亞群及 Th1/ Th2細胞因子的變化及臨床意義。方法採用流式細胞儀及酶聯免疫吸附法(ELISA)分彆檢測50例健康者及30例 AML 患者治療前後 T 淋巴細胞亞群及 Th1/ Th2細胞因子水平。結果初診 AML 患者外週血 CD3+、CD4+、CD4+/ CD8+均顯著低于健康組,CD8+顯著高于健康組,差異具有統計學意義( P ﹤0.05)。治療後,AML 組患者外週血 CD3+、CD4+、CD4+/ CD8+均顯著升高,CD8+顯著降低,與初診時比較差異具有統計學意義( P ﹤0.05),但與健康組比較差異仍具有統計學意義( P ﹤0.05)。初診AML 患者外週血白介素2(IL -2)、榦擾素(IFN -γ)均顯著低于健康組,IL -4、IL -10顯著高于健康組,差異具有統計學意義( P ﹤0.05)。治療後,AML 組患者外週血 IL -2、IFN -γ均顯著升高,IL -4、IL -10顯著降低,與初診時比較差異具有統計學意義( P ﹤0.05),但與健康組比較差異仍具有統計學意義( P ﹤0.05)。結論 T 淋巴細胞亞群及 Th1/Th2細胞因子對 AML 患者病情評估、療效判定及預後評估具有一定臨床價值。以調節 T 淋巴細胞亞群及 Th1/ Th2細胞因子為免疫治療方案,可能為 AML 的臨床治療提供新思路。
목적:탐토급성수성백혈병(AML)환자외주혈 T 림파세포아군급 Th1/ Th2세포인자적변화급림상의의。방법채용류식세포의급매련면역흡부법(ELISA)분별검측50례건강자급30례 AML 환자치료전후 T 림파세포아군급 Th1/ Th2세포인자수평。결과초진 AML 환자외주혈 CD3+、CD4+、CD4+/ CD8+균현저저우건강조,CD8+현저고우건강조,차이구유통계학의의( P ﹤0.05)。치료후,AML 조환자외주혈 CD3+、CD4+、CD4+/ CD8+균현저승고,CD8+현저강저,여초진시비교차이구유통계학의의( P ﹤0.05),단여건강조비교차이잉구유통계학의의( P ﹤0.05)。초진AML 환자외주혈백개소2(IL -2)、간우소(IFN -γ)균현저저우건강조,IL -4、IL -10현저고우건강조,차이구유통계학의의( P ﹤0.05)。치료후,AML 조환자외주혈 IL -2、IFN -γ균현저승고,IL -4、IL -10현저강저,여초진시비교차이구유통계학의의( P ﹤0.05),단여건강조비교차이잉구유통계학의의( P ﹤0.05)。결론 T 림파세포아군급 Th1/Th2세포인자대 AML 환자병정평고、료효판정급예후평고구유일정림상개치。이조절 T 림파세포아군급 Th1/ Th2세포인자위면역치료방안,가능위 AML 적림상치료제공신사로。
Objective To evaluate the change and clinical significance of T - lymphocyte subsets and Th1 / Th2 cytokines in peripheral blood of patients with acute myeloid leukemia( AML). Methods The flow cytometry instrument and enzyme - linked immunosorbent assay (Elisa)was used respectively to detect the T - lymphocyte subsets and Th1 / Th2 cytokines of 50 cases of healthy subjects and 30 cases of AML pa-tients before and after treatment. Results Before treatment,the peripheral blood CD3 + ,CD4 + and CD4 + / CD8 + in AML patients were signifi-cantly lower than healthy group,CD8 + was significantly higher than healthy group,the difference statistically significant( P ﹤ 0. 05). After treat-ment,peripheral blood in patients with AML group CD3 + ,CD4 + and CD4 + / CD8 + were significantly increased,CD8 + decreased significantly, compared with before treatment was statistically significant( P ﹤ 0. 05),but the difference was statistically significant compared with healthy group( P ﹤ 0. 05). Before treatment,the peripheral blood IL - 2 and IFN - γ in AML patients were significantly lower than healthy group. IL -4 and IL - 10 were significantly higher than healthy group,the difference statistically significant( P ﹤ 0. 05). After treatment,IL - 2 and IFN -γ of peripheral blood in patients with AML group were significantly increased,IL - 4 and IL - 10 decreased significantly compared with before treatment. The difference was statistically significant compared with healthy group( P ﹤ 0. 05). Conclusion T - lymphocyte subsets and Th1 /Th2 cytokines may be effective index to evaluate the prognosis of patients with AML. To regulate T lymphocyte subsets and Th1 / Th2 cytokine im-munotherapy program,this method may provide new ideas for the clinical treatment of AML.